On IDSA’s & HIVMA’s Science Speaks blog: Read JID’s latest monthly roundup of papers relevant to clinicians, including articles on a cluster of novel enterovirus cases, cancer risk after TB among people with HIV and other research ready to inform clinical practice. https://bit.ly/3IqghOd

Tickets are available for the Dr. George W. Counts Interest Group dinner at #IDWeek2025! Connect with colleagues who are committed to advancing health equity in the field of ID. 📍 Thrive Restaurant in downtown Atlanta 🕒 Sunday, Oct. 19, from 6:30 to 10 p.m. ET. 🎫: https://bit.ly/46BRSOE

"We recently had a study on reducing infections in newborns halted. Not being able to complete this work has serious negative implications for being able to take care of these vulnerable newborns," shared ID physician Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, of @pennmedicine.bsky.social.

Less than 7% of all physicians in the U.S. are Latino, despite 19% of the population identifying as Latino. Having Latinos better represented in medicine is necessary for the Latino community and the future of medicine in the U.S. Learn more: https://www.nationallatinophysicianday.com/ #NLPD2025

The duration of infectiousness following pulmonary tuberculosis treatment initiation is uncertain. In CID, authors assess whether a bundled intervention designed to decrease respiratory exposure was feasible and would reduce new tuberculosis infections in household contacts. https://bit.ly/4pK8R9b

A new Department of Health and Human Services video pits vaccines against other health priorities like nutrition, exercise and sanitation. Secretary Kennedy's false dichotomy misrepresents the data, contradicts science and puts lives at risk. Our response: https://bit.ly/4nWTCb6

The IDSA Foundation's second annual art auction is now open. Six original paintings by ID physician Ana Velez, MD, FACP, FIDSA, explore retrovirus history and the HIV/AIDS crisis. Auction closes Oct. 21. Place your bid: https://givebutter.com/c/pclXSb/auction

On IDSA’s & HIVMA’s Science Speaks blog: Terri Stillwell, MD, MPH, explores the prevalence of co-infection in febrile infants 61-90 days old with and without respiratory viral infection. https://bit.ly/470Myoi

As you make your #IDWeek2025 plans, don’t miss out on your chance to attend Culture Club: A Celebration of Diversity on Tuesday, Oct. 21, from 7:30 to 11 p.m. ET, hosted by the IDSA Foundation. Claim your tickets now before they sell out! buff.ly/ogRNEap

New #LetsTalkID! ID physician and artist Ana Velez, MD, FACP, joins @paulsaxmd.bsky.social to share how art shapes her work in ID and brings new meaning to medicine. Transcript: bit.ly/3Iu863j Bid now to own her original artwork and support IDSA's mission: givebutter.com/c/pclXSb/auc...

IDSA Foundation board member Dr. Jasmine Marcelin explains the importance of a strong ID workforce, and how it can be attained via the Bio-Preparedness Workforce Pilot Program, during a panel at #ALC54.

Leaders in antimicrobial resistance—your voice is needed! Registration is now open for #IMARI26! Join us Jan 28–30, 2026 in Las Vegas for the premier interdisciplinary meeting tackling #AMR, hosted by @idsainfo.bsky.social and ASM. Register now, space is limited: imari.org/registration/

IDSA Foundation board member Dr. Jasmine Marcelin was in DC this week for #ALC54, an event hosted by the Congressional Black Caucus Foundation. Dr. Marcelin spoke on a panel, highlighting IDSA's efforts to diversify the ID workforce, advance health equity and expand access to care.

ID physicians andrewpaviamd.bsky.social and Helen Y. Chu, MD, FIDSA, discuss last week’s meeting of the Advisory Committee on Immunization Practices, the confusion it has caused around vaccine recommendations and the potential impacts. Watch the press briefing: https://bit.ly/4mz9Jum

Blood-borne viruses (BBV) such as Hepatitis B, Hepatitis C and HIV pose significant personal and public health risks. In OFID, Liam Townsend, BCh, MB, PHD, and colleagues report outcomes of ten years of an opt-out BBV screening program in a large urban emergency department. https://bit.ly/3KfEw24

🚨 Registration is OPEN for #IMARI26! Hosted by IDSA & ASM, top leaders in science, policy & industry will gather Jan 28–30 in Las Vegas for an intimate forum tackling #AMR head-on. Join us: IMARI.org/registration

On IDSA’s & HIVMA’s Science Speaks blog: Three years after mpox made global headlines, the world is seeing two very different realities: one in Africa and another in the rest of the world. Read more from Melvin Sanicas, MD, MSc, MScID, MBA. https://bit.ly/4mlwPob

Clinicians: Appropriate, timely use of antifungals helps protect patient health and combat #AntimicrobialResistance. 💊 Save, print, or bookmark CDC’s fungal pneumonia diagnostic algorithms to help recognize and treat: https://bit.ly/4ly0wml #FungalWeek25

Secretary Kennedy presents a clear and present danger to the American people and their families. This week, even more of our colleagues in the fields of medicine, public health and patient advocacy join us in calling for his resignation. Our full statement: https://bit.ly/42zItEV

Stated at ACIP: COVID-19 vaccines are recommended for people 65 years and older and for individuals 6 months to 64 years old based on individual decision making. Fact: Scientific evidence continues to strongly support broad COVID-19 vaccination.

Support NIH funding! Raise your voice and contact Congress today: RallyForMedicalResearch.org #RallyMedRes #FundNIH

“Without NIH funding, our work would be impossible,” shared an IDSA member and ID physician-scientist in NC. NIH funding makes lifesaving research possible. Urge your congressional representative to support funding for federal ID & HIV programs: https://idsociety.quorum.us/campaign/137216/ #FundNIH

ACIP members are questioning whether the hepatitis B vaccine should continue to be universally administered to children at birth. Fact: Implementation of universal birth dose hepatitis B vaccine is the most effective strategy to prevent childhood infections.

Stated at ACIP: MMRV isn’t acceptable for kids <4 to prevent measles, mumps, rubella & varicella. ❌ False. MMRV/MMR vaccines are safe & highly effective. Studies show only a very small increase in febrile seizure risk after the 1st dose.

Worldwide, fungal diseases and antimicrobial-resistant fungi are increasing. In honor of Fungal Disease Awareness Week, learn about fungal diseases and raise awareness to help reduce the harmful effects of fungal diseases: https://bit.ly/4dyCy6u #FungalWeek25

Only two weeks left! Submit your #AMR research abstract to #IMARI26 and join the global conversation on antimicrobial resistance and innovation. ⏳ Deadline: Wednesday, October 1 at 2 p.m. ET 👉 IMARI.org/call-for-abstracts

What are the biggest barriers to achieving equitable vaccine access? Tina Tan, President, @idsainfo.bsky.social shares priorities, challenges, and innovations shaping the field of microbiology and infectious diseases. Read her full interview here: www.emjreviews.com/en-us/amj/mi...

In a new @nytimes.com op-ed, primary care physician Danielle Ofri, MD, PhD, lists IDSA as one of the "best sources of scientifically validated recommendations" for vaccinations. bit.ly/3VgyOzf *subscription required

HIV resistance to antiretrovirals can undermine the health benefits conferred by ART. In CID, Ingrid A Beck and colleagues hypothesized that #HIV-dolutegravir-resistance is more frequent when co-administered with nucleos(t)ides with shorter intracellular half-lives. https://bit.ly/4gmBKE0

Happening now! IDSA is part of 24 Hours to Save AIDS Research. Join us NOW as scientists, researchers, and advocates showcase successes in HIV research and call for an end to federal budget cuts and project terminations. Watch the livestream: https://bit.ly/41WAMbF

Join your friends, colleagues and your ID community at #IDWeek2025 for Culture Club: A Celebration of Diversity! Get ready for a night of music, fellowship and fun with a dance floor and rooftop views of Atlanta. 🎵💃🌆 Learn more and purchase tickets: https://bit.ly/4nwZPdC

Tickets are now available for the Dr. George W. Counts Interest Group dinner at #IDWeek2025! Connect with colleagues who are committed to advancing health equity in the field of ID. 📍 Thrive Restaurant in Atlanta 🕒 Sunday, Oct. 19 at 6:30 p.m. ET. 🎫: https://bit.ly/46BRSOE

On IDSA’s & HIVMA’s Science Speaks blog: Aldon Li, MD, FIDSA, explores the efficacy and safety of fecal microbiota transplantation for primary C. difficile infection. https://www.idsociety.org/science-speaks-blog/2025/can-you-use-fmt-as-first-line-treatment-for-c.-difficile-infection

Behind every infectious disease breakthrough is research. This #MedicalResearchMonth, we honor the discoveries that protect lives worldwide. #FundNIH

IDSA is proud to support 24 Hours to Save AIDS Research. Join us September 16 starting at 11am ET to learn what HIV research has achieved through federal investments and what we stand to lose. Register: http://bit.ly/45U1keO or join us on YouTube: http://bit.ly/45Qftts

Together, we’re building a stronger, more inclusive ID community. 🧫 Support fellowships, mentorship, and career development programs that shape the future of our field. https://givetothe.idsafoundation.org/campaign/678493/donate

🗣Your voice is needed! ACIP meets Sept. 18-19 to discuss vaccines, incl. COVID-19, RSV and MMRV. Clinicians and scientists must speak up on why vaccines save lives and access must remain broad. Take 2 min and submit your comment: https://idsociety.quorum.us/campaign/139983/ Deadline: Sat. Sept. 13

The Make Our Children Healthy Again report released today underscores the vital role of infectious diseases and public health experts in all efforts to improve children’s health. Our statement: https://bit.ly/41IlBmu

Hear IDSA members Helen Chu, MD, MPH, and Yvonne “Bonnie” Maldonado, MD, speak on navigating vaccine uncertainty during a spotlight forum hosted by @bluntrochester.senate.gov tomorrow, Sept 10, 2:30-4:30pm. Watch the livestream: https://www.facebook.com/SenLBR

In OFID, Yuki Nakano and colleagues investigate the signals and characterize the clinical features of optic nerve disorders related to oxazolidinones using the FAERS database. https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaf520/8242009

Asymptomatic bacteriuria (ASB) is generally systematically screened and treated with antibiotics in kidney transplant recipients (KTRs). In OFID, authors explore the role of antibiotic therapy in management of ASB in KTRs. https://bit.ly/3JQye8M

On IDSA’s & HIVMA’s Science Speaks blog: Now is pivotal moment in sustaining funding for medical research. HIVMA Chair Colleen Kelley, MD, MPH, FIDSA, shares key steps to advocate for ID and HIV funding. https://bit.ly/47vcvNr

IDSA advocates hosted Duncan Miller, Sen. Husted's deputy regional director, at Case Western to discuss strengthening the ID workforce, boosting research investments, and showcase their work in research and patient care. Learn how you can get involved: https://www.idsociety.org/map

We all remember our first step into ID—now it’s your turn to help someone else take theirs! Join the IDSA Foundation in supporting the next generation of ID: https://givetothe.idsafoundation.org/campaign/678493/donate

On IDSA’s & HIVMA’s Science Speaks blog: Learn about JID’s latest monthly roundup of papers relevant to clinicians, including new insights into severe bronchiolitis, vaccine hesitancy, cefepime-taniborbactam and more. https://bit.ly/3V2KSUB

As national medical, scientific, public health and patient organizations, we call for the resignation of HHS Secretary Robert F. Kennedy Jr. to ensure the health of the American people. Our statement: https://bit.ly/45LeJHi

In CID, Maria Ines Figueroa and colleagues evaluated the antiviral activity of dolutegravir/lamivudine among antiretroviral therapy (ART)-naive patients with HIV with a CD4 count ≤200 cells/mm³. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf415/8241230

On Science Speaks blog: Several authors of IDSA’s new guidelines on the management and treatment of complicated urinary tract infections answer questions about new recommendations and updates. www.idsociety.org/science-spea...

🚨Deadline tomorrow! Only a few spots left in IDSA’s online-only Rising Leaders program for early career ID/HIV professionals. Level up your leadership with: ✅ Career strategies ✅ Leadership coaching ($1,750 value!) ✅ and more! Apply by Aug. 30: https://bit.ly/4eQ28FB

Join IDSA Fellows Community of Practice & cpsolvers.bsky.social ‬for a Fellows Case Conference TOMORROW at 3PM ET! This session will incl. a case presentation & discussion, ft. Daniel Minter, MD, & Varun Phadke, MD. Register: https://societycentral.zoom.us/meeting/register/-pqoJjuTRTO66CWF7XPFIw